Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia Disease Penetrance and Expression in Cardiac Ryanodine Receptor Mutation-Carrying Relatives

被引:128
|
作者
van der Werf, Christian [1 ]
Nederend, Ineke [1 ]
Hofman, Nynke [2 ]
van Geloven, Nan [3 ]
Ebink, Corne [4 ]
Frohn-Mulder, Ingrid M. E. [5 ]
Alings, A. Marco W. [6 ]
Bosker, Hans A. [2 ,7 ]
Bracke, Frank A. [8 ]
van den Heuvel, Freek [9 ]
Waalewijn, Reinier A. [12 ]
Bikker, Hennie
van Tintelen, J. Peter [10 ]
Bhuiyan, Zahurul A. [2 ,13 ]
van den Berg, Maarten P. [11 ]
Wilde, Arthur A. M. [1 ]
机构
[1] Univ Amsterdam, Dept Cardiol, Heart Failure Res Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands
[4] Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands
[5] Erasmus MC Sophia, Div Pediat Cardiol, Dept Pediat, Rotterdam, Netherlands
[6] Amphia Hosp, Dept Cardiol, Breda, Netherlands
[7] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands
[8] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands
[9] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Pediat Cardiol, NL-9700 AB Groningen, Netherlands
[10] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[11] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[12] Gelre Hosp, Dept Cardiol, Apeldoorn, Netherlands
[13] CHU Vaudois, Gen Med Serv, Lab Genet Mol, Lausanne, Switzerland
来源
关键词
catecholaminergic polymorphic ventricular tachycardia; death; sudden; genetics; ion channels; tachyarrhythmias; ARRHYTHMIA SYNDROMES; RELEASE CHANNEL; SUDDEN-DEATH; FOLLOW-UP; GENE; DYSFUNCTION; MECHANISM; SPECTRUM; FEATURES; CARRIERS;
D O I
10.1161/CIRCEP.112.970517
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome associated with mutations in the cardiac ryanodine receptor gene (RYR2) in the majority of patients. Previous studies of CPVT patients mainly involved probands, so current insight into disease penetrance, expression, genotype-phenotype correlations, and arrhythmic event rates in relatives carrying a RYR2 mutation is limited. Methods and Results-One-hundred sixteen relatives carrying a RYR2 mutation from 15 families who were identified by cascade screening of the RYR2 mutation causing CPVT in the proband were clinically characterized, including 61 relatives from 1 family. Fifty-four of 108 antiarrhythmic drug-free relatives (50%) had a CPVT phenotype at the first cardiological examination, including 27 (25%) with nonsustained ventricular tachycardia. Relatives carrying a RYR2 mutation in the C-terminal channel-forming domain showed an increased odds of nonsustained ventricular tachycardia (odds ratio, 4.1; 95% CI, 1.5-11.5; P=0.007, compared with N-terminal domain). Sinus bradycardia was observed in 19% of relatives, whereas other supraventricular dysrhythmias were present in 16%. Ninety-eight (most actively treated) relatives (84%) were followed up for a median of 4.7 years (range, 0.3-19.0 years). During follow-up, 2 asymptomatic relatives experienced exercise-induced syncope. One relative was not being treated, whereas the other was noncompliant. None of the 116 relatives died of CPVT during a 6.7-year follow-up (range, 1.4-20.9 years). Conclusions-Relatives carrying an RYR2 mutation show a marked phenotypic diversity. The vast majority do not have signs of supraventricular disease manifestations. Mutation location may be associated with severity of the phenotype. The arrhythmic event rate during follow-up was low. (Circ Arrhythm Electrophysiol. 2012;5:748-756.)
引用
收藏
页码:748 / 756
页数:9
相关论文
共 50 条
  • [2] Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia
    Jiang, Dawei
    Jones, Peter P.
    Davis, Darryl R.
    Gow, Robert
    Green, Martin S.
    Birnie, David H.
    Chen, S. R. Wayne
    Gollob, Michael H.
    CHANNELS, 2010, 4 (04) : 302 - 310
  • [3] A case report of familial catecholaminergic polymorphic ventricular tachycardia with a novel mutation in the ryanodine receptor 2
    Shoji, Yoshikuni
    Hayashida, Satoshi
    Masuda, Hikaru
    Tachibana, Eizo
    Okumura, Yasuo
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2024, 8 (12)
  • [4] Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function
    Zhao, Yan-Ting
    Valdivia, Carmen R.
    Gurrola, Georgina B.
    Powers, Patricia P.
    Willis, B. Cicero
    Moss, Richard L.
    Jalife, Jose
    Valdivia, Hector H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (13) : E1669 - E1677
  • [5] Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene
    Nof, Eyal
    Belhassen, Bernard
    Arad, Michael
    Bhuiyan, Zahurul A.
    Antzelevitch, Charles
    Rosso, Raphael
    Fogelman, Rami
    Luria, David
    El-Ani, Dalia
    Mannens, Marcel M. A. M.
    Viskin, Sami
    Eldar, Michael
    Wilde, Arthur A. M.
    Glikson, Michael
    HEART RHYTHM, 2011, 8 (10) : 1546 - 1552
  • [6] Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia
    Wangueemert, Fernando
    Bosch Calero, Cristina
    Perez, Carmelo
    Campuzano, Oscar
    Beltran-Alvarez, Pedro
    Scornik, Fabiana S.
    Iglesias, Anna
    Berne, Paola
    Allegue, Catarina
    Ruiz Hernandez, Pablo M.
    Brugada, Josep
    Perez, Guillermo J.
    Brugada, Ramon
    HEART RHYTHM, 2015, 12 (07) : 1636 - 1643
  • [7] Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia
    Marks, AR
    Priori, S
    Memmi, M
    Kontula, K
    Laitinen, PJ
    JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (01) : 1 - 6
  • [8] Age related and incomplete penetrance of the P4902S missense mutation of the cardiac ryanodine receptor gene in familial polymorphic ventricular tachycardia
    Postma, AV
    Kamblock, J
    Berthet, M
    Denjoy, I
    Guicheney, P
    CIRCULATION, 2001, 104 (17) : 746 - 746
  • [9] Verapamil Prevents Fatal Arrhythmia by Blocking Cardiac Ryanodine Receptor in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia Carrying Calsequestrin-2 Mutation
    Wakimoto, Hiroko
    Alcalai, Ronny
    Wang, Libin
    Arad, Michael
    Konno, Tetsuo
    Seidman, Jonathan G.
    Seidman, Christine E.
    Berul, Charles I.
    CIRCULATION, 2009, 120 (18) : S615 - S615
  • [10] Novel Ryanodine Receptor 2 Mutation Associated with a Severe Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia
    LaPage, Martin J.
    Russell, Mark W.
    Bradley, David J.
    Dick, Macdonald, II
    JOURNAL OF PEDIATRICS, 2012, 161 (02): : 362 - 364